» Articles » PMID: 39261383

Lacidipine Inhibits NF-κB and Notch Pathways and Mitigates DSS-Induced Colitis

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2024 Sep 11
PMID 39261383
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Ulcerative colitis (UC) is a chronic inflammatory condition affecting the colon, with a global incidence that is rising. Despite the increasing prevalence, effective treatment options for UC remain limited.

Methods: We utilized an NF-κB promoter dual fluorescence reporter system to screen for compounds that could inhibit p65 and IκBα phosphorylation. The anti-hypertension drug lacidipine was identified as a candidate. Its efficacy was further evaluated in a murine model of dextran sulfate sodium (DSS)-induced colitis. The analysis included the assessment of colon lesions, inflammation markers, and signal pathway activation, with a focus on NF-κB and Notch signaling.

Results: Lacidipine effectively inhibited p65 and IκBα phosphorylation in the reporter system. In the DSS-induced colitis murine model, lacidipine treatment led to a reduction in colon lesions and inflammatory markers. Target analysis showed significant enrichment of the Notch signaling pathway. Additionally, lacidipine inhibited both NF-κB and Notch activation in DSS-stimulated colons.

Conclusion: Lacidipine demonstrated a protective effect in UC, reducing inflammation and modulating key signaling pathways. These findings suggest that lacidipine could be a promising candidate for the treatment of UC.

References
1.
Ashburn T, Thor K . Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004; 3(8):673-83. DOI: 10.1038/nrd1468. View

2.
Zhu C, Li K, Peng X, Yao T, Wang Z, Hu P . Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy. Front Immunol. 2022; 13:1083788. PMC: 9763584. DOI: 10.3389/fimmu.2022.1083788. View

3.
Bai L, Scott M, Steinberg E, Kalesinskas L, Habtezion A, Shah N . Computational drug repositioning of atorvastatin for ulcerative colitis. J Am Med Inform Assoc. 2021; 28(11):2325-2335. PMC: 8510297. DOI: 10.1093/jamia/ocab165. View

4.
Wang X, Gao Y, Wang L, Yang D, Bu W, Gou L . Troxerutin Improves Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice. J Agric Food Chem. 2021; 69(9):2729-2744. DOI: 10.1021/acs.jafc.0c06755. View

5.
Abdelhamid A, Youssef M, Cavalu S, Mostafa-Hedeab G, Youssef A, Elazab S . Carbocisteine as a Modulator of Nrf2/HO-1 and NFκB Interplay in Rats: New Inspiration for the Revival of an Old Drug for Treating Ulcerative Colitis. Front Pharmacol. 2022; 13:887233. PMC: 9214041. DOI: 10.3389/fphar.2022.887233. View